Immune suppression in the early stage of COVID-19 disease
How COVID-19 pathology differs from other drivers of pneumonia is unclear. Here the authors analyze urine from patients with COVID-19 and identify an immunosuppressive protein expression pattern that is distinct from the pattern in healthy individuals or patients with non-COVID-19 pneumonia.
Saved in:
Main Authors: | Wenmin Tian, Nan Zhang, Ronghua Jin, Yingmei Feng, Siyuan Wang, Shuaixin Gao, Ruqin Gao, Guizhen Wu, Di Tian, Wenjie Tan, Yang Chen, George Fu Gao, Catherine C. L. Wong |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/788f9dfbff9d42378d21e26566e71d04 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage
by: Juan Liu, et al.
Published: (2017) -
THE INFLUENCE OF STEM CELLS ON EARLY STAGES OF THE GRAFT IMMUNITY
by: V. A. Lyashenko, et al.
Published: (2014) -
The homeobox protein VentX reverts immune suppression in the tumor microenvironment
by: Yi Le, et al.
Published: (2018) -
Early Immune Response Elicited by Different Trypanosoma cruzi Infective Stages
by: Brenda Celeste Gutierrez, et al.
Published: (2021) -
Comparison of Clinical Characteristics for Distinguishing COVID-19 From Influenza During the Early Stages in Guangdong, China
by: Yongzhi Li, et al.
Published: (2021)